| Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified studied in …STUDIED_INderived46 of 46show fewer |
|---|
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03613532Phase 1 · active not recruiting Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787487Phase 2 · completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01894477Phase 2 · unknown Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03807063Phase 1 · withdrawn Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01305200Phase 3 · completed Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039091Phase 1 · terminated Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02210858Phase 1/Phase 2 · completed Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00530218Phase 2 · completed Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00988715Phase 1 · completed Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652014Phase 2 · withdrawn Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056614Phase 2 · completed Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509249Phase 2 · terminated Aflibercept in Treating Patients With Myelodysplastic Syndromes · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00351975Phase 1 · completed Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00322101Phase 3 · completed Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233921NA · completed Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049582Phase 1 · terminated Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331513Phase 1 · completed Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357305Phase 1 · completed Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357708Phase 1 · completed Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00799461Phase 3 · completed Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications · condition mapped ALIAS · 46 trials mapped (3 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |